Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Stryker acquires Inari Medical for $4.9B
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.

‘History is unfortunately repeating itself’: 6 things to know about the potential heparin shortage

A possible shortage of heparin, one of the most popular blood thinners on the market, is threatening the U.S., according to a viewpoint published in The Lancet on Jan. 23.

January 24, 2020

What the EVALI epidemic means for public health

The jury is out: vaping, or e-cigarette use, is a national epidemic in the U.S.

January 23, 2020

Death, amputation more common with paclitaxel-coated devices vs. conventional angioplasty

A recent meta-analysis published in the Journal of Vascular and Interventional Radiology supports evidence that paclitaxel-coated balloons may pose more risk than reward for patients with symptoms of critical limb ischemia.

January 22, 2020

Experimental hemophilia drug could be the most expensive in the world

Biotech company BioMarin Pharmaceutical is considering a price point of between $2 million and $3 million for its novel experimental gene therapy for hemophilia patients, the Wall Street Journal reported Jan. 16.

January 21, 2020

More than 2M heart patients use marijuana

A review published in the Journal of the American College of Cardiology this month suggests that an excess of 2 million patients with cardiovascular disease also use marijuana.

January 21, 2020

Mechanical hyperventilation could streamline cardiac ablation

A medical technique that involves safely hyperventilating conscious, unmedicated patients could facilitate the use of radiotherapy for cardiac ablation, according to research published in Frontiers in Physiology.

January 20, 2020

Smoking hookah may increase risk of thrombosis

A mouse study has revealed that smoking hookah—inhaling tobacco through a long water pipe—can cause blood to function abnormally and clot.

January 17, 2020

1 in 6 cases of EVALI can be traced back to legal THC vapes

Data released by the Centers for Disease Control and Prevention on Jan. 14 revealed that one in six cases of vaping-related lung illness, or EVALI, can be linked to legally purchased cannabis products.

January 16, 2020

Vascular & Endovascular

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Stryker acquires Inari Medical for $4.9B

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk